Meningococcal C conjugate vaccine: The experience in England and Wales
- 23 May 2009
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 27, B20-B29
- https://doi.org/10.1016/j.vaccine.2009.04.067
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United KingdomClinical and Vaccine Immunology, 2009
- Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination EraClinical and Vaccine Immunology, 2008
- Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyBMJ, 2008
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndromeArchives of Disease in Childhood, 2007
- No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and WalesThe Lancet Infectious Diseases, 2006
- Haemophilus influenzaeType b Reemergence after Combination ImmunizationEmerging Infectious Diseases, 2006
- Recent emergence of serogroup C meningococcal disease in GreeceFEMS Immunology & Medical Microbiology, 1999
- Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup CEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Meningococcal vaccine in sub-Saharan AfricaThe Lancet, 1997